Advocacy intelligence hub — real-time data for patient organizations
Loma Linda University — NA
University of Texas Southwestern Medical Center — NA
The Children's Hospital of Zhejiang University School of Medicine — PHASE4
Mayo Clinic
Hackensack Meridian Health — NA
Neola Medical Inc — NA
Murdoch Childrens Research Institute — NA
Uludag University — PHASE4
Jiulongpo No.1 People's Hospital — NA
Medical University of Graz — PHASE4
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance3
Curosurf
(Pulmonary surfactant replacement, porcine)Orphan drugChiesi USA, Inc.
Surfactant [EPC]
12.1 Mechanism of Action Endogenous pulmonary surfactant reduces surface tension at the air-liquid interface of the alveoli during ventilation and sta...
Survanta intratracheal suspension
(Beractant)Orphan drugRoss Laboratories
Surfactant [EPC]
Infasurf
(calfactant)Orphan drugstandardONY Biotech Inc.
Surfactant [EPC]
Browse all Infant acute respiratory distress syndrome news →
Christian Heiring
Rigshospitalet, Denmark
Filip Cools, PhD
Universitair Ziekenhuis Brussel
Axel R Franz, MD
University Hospital Tuebingen
William A. Carey, MD
Mayo Clinic
Beena G. Sood, MD, MS, MD
Wayne State University
📍 DETROIT, MI
Guillaume Emeriaud, MD PhD
CHU Sainte Justine, Université de Montréal
View all Infant acute respiratory distress syndrome specialists →